Biblio

Author Title Type [ Year

]

Filters: Author is Liu, Hui [Clear All Filters]

2024

Xie Z, Jiang W, Liu H, Chen L, Xuan C, Wang Z, Shi X, Lin Z, Gao X. Antimicrobial Peptide- and Dentin Matrix-Functionalized Hydrogel for Vital Pulp Therapy via Synergistic Bacteriostasis, Immunomodulation and Dentinogenesis. Adv Healthc Mater. 2024:e2303709.

Shen Z, Wang Y, Xie R, Zhang Q, Xing X, Zhang S, Liu H, Sang W. Clinicopathologic features and survival outcomes of CD30 expression in extranodal natural killer/T-cell lymphoma. Am J Clin Pathol. 2024.

Jia X, Liao N, Yu S, Li H, Liu H, Zhang H, Xu J, Yao Y, He H, Yu G, et al. Impact of measurable residual disease in combination with CD19 on postremission therapy choices for adult t(8;21) acute myeloid leukemia in first complete remission. Cancer Med. 2024;13(4):e7074.

de Latour RPeffault, Röth A, Kulasekararaj AG, Han B, Scheinberg P, Maciejewski JP, Ueda Y, de Castro CM, Di Bona E, Fu R, et al. Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria. N Engl J Med. 2024;390(11):994-1008.

2023

Tong B, Liao Z, Liu H, Ke W, Lei C, Zhang W, Liang H, Wang H, He Y, Lei J, et al. Augmenting Intracellular Cargo Delivery of Extracellular Vesicles in Hypoxic Tissues through Inhibiting Hypoxia-Induced Endocytic Recycling. ACS Nano. 2023.

Wang Y, Yu H, Yu M, Liu H, Zhang B, Wang Y, Zhao S, Xia Q. CD24 blockade as a novel strategy for cancer treatment. Int Immunopharmacol. 2023;121:110557.

Fei M-Y, Wang Y, Chang B-H, Xue K, Dong F, Huang D, Li X-Y, Li Z-J, Hu C-L, Liu P, et al. The cell non-autonomous function of ID1 promotes AML progression via ANGPTL7 from the microenvironment. Blood. 2023.

Liu H, Zhao Z, Zhao J, Xu L, Li J, Zhang B. Derivation of induced pluripotent stem cell SHEHDNi002-A from a 68-year-old Chinese Han Parkinson's disease patient carrying LRRK2 and DNAJC6 mutations. Stem Cell Res. 2023;75:103297.

Sun J, Liu Q, Jiang Y, Cai Z, Liu H, Zuo H. Engineered small extracellular vesicles loaded with miR-654-5p promote ferroptosis by targeting HSPB1 to alleviate sorafenib resistance in hepatocellular carcinoma. Cell Death Discov. 2023;9(1):362.

Wu J, Zhang LC, Liu H, Zhang J, Tang PF. Exosomes promote hFOB1.19 proliferation and differentiation via LINC00520. J Orthop Surg Res. 2023;18(1):546.

Shao R, Zhang Y, He J, Huang F, Fan Z, Yang K, Xu Y, Xu N, Luo Y, Deng L, et al. Impact of genetic patterns on sorafenib efficacy in patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation: a multi-center, cohort study. Signal Transduct Target Ther. 2023;8(1):348.

An Z-Y, Wu Y-J, Hou Y, Mei H, Nong W-X, Li W-Q, Zhou H, Feng R, Shen J-P, Peng J, et al. A life-threatening bleeding prediction model for immune thrombocytopenia based on personalized machine learning: a nationwide prospective cohort study. Sci Bull (Beijing). 2023.

Wang H, Liu H, Li L, Chen Y, Liu Z, Li L, Ding S, Ding K, Fu R. Long noncoding RNA FAM157C contributes to clonal proliferation in paroxysmal nocturnal hemoglobinuria. Ann Hematol. 2023.

Li Q, Liu H, Li L, Guo H, Xie Z, Kong X, Xu J, Zhang J, Chen Y, Zhang Z, et al. Mettl1-mediated internal mG methylation of Sptbn2 mRNA elicits neurogenesis and anti-alzheimer's disease. Cell Biosci. 2023;13(1):183.

Ma J, Shao L, Fuksenko T, Liu H, Shi R, Dinh A, Highfill SL, Zhang N, Panch SR, Somerville RP, et al. Reference gene selection for clinical chimeric antigen receptor T-cell product vector copy number assays. Cytotherapy. 2023.

Xuan L, Wang Y, Yang K, Shao R, Huang F, Fan Z, Chi P, Xu Y, Xu N, Deng L, et al. Sorafenib maintenance after allogeneic haemopoietic stem-cell transplantation in patients with FLT3-ITD acute myeloid leukaemia: long-term follow-up of an open-label, multicentre, randomised, phase 3 trial. Lancet Haematol. 2023.

Liu H, Jiang C, Peng J, Hu X, Xia Y. Transplantation of Neural Stem Cells-Overexpressed Ku70 Improves Neurological Deficits in a Mice Model of Cerebral Ischemia Stroke. Neurochem Res. 2023.

Hui Y-J, Chen H, Peng X-C, Li L-G, Di M-J, Liu H, Hu X-H, Yang Y, Zhao K-L, Li T-F, et al. Up-regulation of ABCG2 by MYBL2 deletion drives Chlorin e6-mediated photodynamic therapy resistance in colorectal cancer. Photodiagnosis Photodyn Ther. 2023:103558.

2022

Liu W, Ji J, Zou D, Cao Y, Xu Y, Zhou J, Gao S, Wang F, Chen W, Du J, et al. Autologous hematopoietic stem cell transplantation activity for lymphoma and multiple myeloma in China. Bone Marrow Transplant. 2022.

Liu H, Zhang L, Li M, Zhao F, Lu F, Zhang F, Chen S, Guo J, Zhang R, Yin H. Bone mesenchymal stem cell-derived extracellular vesicles inhibit DAPK1-mediated inflammation by delivering miR-191 to macrophages. Biochem Biophys Res Commun. 2022;598:32-39.

Huang F, Zeng X, Fan Z, Xu N, Yu S, Xuan L, Liu H, Jin H, Lin R, Shi P, et al. Haplo-peripheral blood stem cell plus cord blood grafts for hematologic malignancies might lead to lower relapse compared with haplo-peripheral blood stem cell plus bone marrow grafts. Transplant Cell Ther. 2022.

Ye X, Wu Y, Xu J, Liu H, Wang H, Li Q, Li Q, Xuan A. PPARβ mediates mangiferin-induced neuronal differentiation of neural stem cells through DNA demethylation. Pharmacol Res. 2022:106235.

Wang J, Jiang H, Jing Y, Su L, Liu D, Zhou D, Wang J, Liu H, Ruan GRui, Gao S, et al. Prognostic implications of the detection of measurable residual disease and mutations based on next-generation sequencing in acute myeloid leukaemia with biallelic mutations of CEBPA. Br J Haematol. 2022.

Deng P, Wang Z, Chen J, Liu S, Yao X, Liu S, Liu L, Yu Z, Huang Y, Xiong Z, et al. RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancer. J Clin Invest. 2022.

Wu J, Wu D, Wu G, Bei H-P, Li Z, Xu H, Wang Y, Wu D, Liu H, Shi S, et al. Scale-out production of extracellular vesicles derived from natural killer cells via mechanical stimulation in a seesaw-motion bioreactor for cancer therapy. Biofabrication. 2022.

Pages